




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
42501272-E-男A(02中央單位02.(14國有企 06.外商投資企 11.高等院集體企 07.有限責(zé)任公 12.研究院私營企 08.股份有限公 13.社會團聯(lián)營企 22689684574426%()認(rèn)定的高新技術(shù)企 高等院校辦的企 科研院所辦的企 無(2) .(PCI)是目前治療AMI的最有效方法,可使AMI的死亡率降低30%以上。急診PCI的主要作用是及時開通閉塞的冠脈,減少心肌壞死,促進心功能恢復(fù),從而降低死亡率。恢復(fù)血流、實現(xiàn)心肌再灌注是急診PCI改善預(yù)后的關(guān)鍵,但根據(jù)傳統(tǒng)的TIMI血流分級方法所確定的冠脈血流恢復(fù)情況有時并不能反應(yīng)心肌再灌注的真實情況,臨床上常出現(xiàn)病人血流雖然恢復(fù),但仍存在心電圖ST盾結(jié)果。因此研究者一直在尋找其它更可靠的再灌注評價方法。ECT及PET等方面進行評價,1)胞、磷酸肌酸激酶(CK)、血糖、粘附分子、BP、RP、TNF等。這些指標(biāo)在心肌得到及時再灌注后也此除常規(guī)的循環(huán)靜脈血樣本之外,研究者還直接自冠狀靜脈竇和梗死相關(guān)動脈分別取血標(biāo)本進行檢測。血常規(guī)檢查:研究顯示發(fā)病時血白細(xì)胞升高的AMI患者急診PCI后的預(yù)后相對較差[1][3細(xì)胞也是炎癥的一個指標(biāo),AMI發(fā)病時多形核細(xì)胞升高與PCI后的灌注不良相關(guān)[4]。血小板是動脈血栓形成的關(guān)鍵因素,在AMI發(fā)病時血小板數(shù)量升高將導(dǎo)致冠脈灌注不良,并與PCI后6個月的死亡相關(guān)[5]。顯示SigmaSTR與MB(myocardialblush)均能很好地作為急診PCI術(shù)后的預(yù)后判斷指標(biāo)[17]、18],而單純的的房撲和房顫是急診PCI后1年死亡的獨立預(yù)測指標(biāo)[25]。AMI還可出現(xiàn)QRS時程的增寬,并提示遠期(2灌注顯影分級(TIMIMyocardialBlushGrade,MBG)。sofoITMIII級血流,急診PCI才可能使病人真正獲益。TIMI血流分級能夠較好地反應(yīng)梗死相關(guān)動脈的開通情況,并與預(yù)后有較好的相關(guān)性,一直沿用至今。但TIMI診PCI后IMI1、2],0%TIMIST,TII]。TIMI血流幀數(shù)(TFC):是反應(yīng)梗死相關(guān)動脈血流恢復(fù)情況的更可靠指標(biāo)。計數(shù)自造影劑開始充盈冠脈至標(biāo)準(zhǔn)化遠端血管標(biāo)記顯影所需的幀數(shù)。標(biāo)準(zhǔn)化遠端血管標(biāo)記因血管而異,前降支為其最遠端分叉、回旋支為鈍緣支最遠端分叉、右冠為左室后側(cè)支遠端分叉,而前降支因血管較長需除以.7來進行校正。按國際上常用的標(biāo)準(zhǔn)化圖像采集速度30幀/秒,評價的標(biāo)準(zhǔn)是TII血流幀數(shù)<7幀為正常血流。在應(yīng)用硝酸鹽后由血管擴張,TFC計數(shù)也要增加6幀進行校正。TIMI血流幀數(shù)能夠使血流分級標(biāo)準(zhǔn)化而具有可比性,研究顯示與住院期間死亡率以及梗死相關(guān)動脈再狹窄相關(guān)。TIMI心肌灌注分級(TMPG):根據(jù)造影劑經(jīng)過微血管進入心肌使其染色的能力,反應(yīng)心肌微血管灌注3:TPG級)1級、2級3后能夠消失)、3級(正常顯影,造影劑在3個心動周期內(nèi)消失,與非梗死區(qū)相同)。TMPG強調(diào)造影劑進入TMP與AI30TIMI心肌灌注顯影分級(MBG):能夠反應(yīng)心肌組織灌注情況,最早由Van’tHof提出的主要針對PCI術(shù)血管內(nèi)超聲(IVUS):血管內(nèi)超聲多應(yīng)用于擇期PCI冠脈內(nèi)超聲心肌聲學(xué)造影能夠直接檢測經(jīng)冠脈注射的聲學(xué)造影劑在心肌組織的分布情況,是反應(yīng)心肌在組織水平灌注的可靠方法。心肌聲學(xué)造影技術(shù)主要是運用比紅細(xì)胞直徑還小的造影劑顆粒,在灌注區(qū)域和無灌注區(qū)域產(chǎn)生不同的超聲云霧狀影像增強,直接觀察心肌的灌注狀態(tài)。冠狀動脈造影只能顯示心外膜直徑大于100um的小動脈,并非真正意義上的微循環(huán)。選擇性心肌造影技術(shù),即在冠狀動脈造影時選擇性將造影劑注入目標(biāo)冠狀動脈,通過超聲心動圖顯示該冠狀動脈供血區(qū)域造影劑顯示情況并進行評分,完全顯影為1050PC發(fā)[肌聲學(xué)造影似乎具有相同價值[16]。9mTc-6h患者的再灌注時間和療效。當(dāng)患者明確為AMI時收住院,即刻注射99mTc-MIBI740MBq,之后,立即開始手術(shù)和內(nèi)科治療,待患者病情平穩(wěn)后,行術(shù)前的心肌顯像,反映的是術(shù)前的心肌血流分布情況。~799mT-MIBI[1-6診檢查項目,為臨床療效判斷提供客觀指征。,18F-量進一步減少,導(dǎo)致心肌細(xì)胞壞死,心肌代謝活動停止,不能攝取葡萄糖和FDG。因此,PET是檢測心肌[7-11PC術(shù)即刻心肌再灌注情況的判斷,而是多作為術(shù)后心肌恢復(fù)情況以及預(yù)后的判斷指標(biāo)。對于局部心肌灌注和代謝圖像的分析,主要有兩類,一類為心肌灌注減低區(qū)對18F-FDG的攝取正常或明顯增加,稱為“灌注-代謝不匹配(mismatch,MM)”,表明心肌存活;而另一類為灌注減低區(qū)對18F-FDG攝取亦受損,稱“灌注-代謝相匹配(match,M)”,表明心肌梗死[8~12](partialmismtch,PM),對其臨床價值目前手術(shù)前后心肌灌注的變化和術(shù)后心肌代謝情況就能比較好地評價手術(shù)效果。,并24小時待命,隨時為AMI病人進行急診手術(shù)。兩間專用導(dǎo)管室,配備有呼吸機、IABP、血管內(nèi)超聲等各種搶救和檢查設(shè)備。中心實驗室配備有實驗所需的流式細(xì)胞儀等各種設(shè)備,同位素室配備有最新的ECT、SPECT以及PET。5)、本課題將委托專業(yè)統(tǒng)計學(xué)人員處理所有數(shù)據(jù),以保證結(jié)果的可靠性。建立?;A(chǔ)。Comparan-NunezA,PalaciosJM,Jerjes-SanchezCD.Leucocytosisassociatedwithhigherincidenceofadversecardiovasculareventsinmyocardialinfarcts.ArchCardiolMex.2005;75Suppl3:S3-61-8.BlumA,MassachiR,MillerH.Thepredictivevalueofwhitebloodcellcountonthesuccessofprimaryinfarction.EurJInternMed.2004;15(3):176-180.KojimaS,SakamotoT,IshiharaM,KimuraK,MiyazakiS.Thewhitebloodcellcountisanindependentpredictorofno-reflowandmortalityfollowingacutemyocardialinfarctioninthecoronaryinterventionalera.AnnMed.LinkA,SchwerdtH,HennenB,BohmM.Polymorphonuclearneutrophilsinmyocardialischemiaandreperfusioninjury.Influenceofcoronaryintervention?ZKardiol.2004;93(8):605-11.HuczekZ,KochmanJ,FilipiakKJ,HorszczarukGJ,GrabowskiM.Meanplateletvolumeonadmissionpredictsimpairedreperfusionandlong-termmortalityinacutemyocardialinfarctiontreatedwithprimarypercutaneouscoronaryintervention.JAmCollCardiol.2005;46(2):284-90.HalkinA,StoneGW,GrinesCL,CoxDA,RutherfordBD.Prognosticimplicationsofcreatinekinaseelevationafterprimarypercutaneouscoronaryinterventionforacutemyocardialinfarction.JAmCollCardiol.2006;47(5):951-61.PrasadA,StoneGW,StuckeyTD,CostantiniCO,ZimetbaumPJ.ImpactofdiabetesmellitusonmyocardialTimmerJR,vanderHorstIC,OttervangerJP,HenriquesJP,HoorntjeJC.Prognosticvalueofadmissionglucoseinnon-diabeticpatientswithmyocardialinfarction.AmHeartJ.2004;148(3):399-404.IshiiH,IchimiyaS,KanashiroM,AmanoT,MatsubaraT,MuroharaT.Effectsofintravenousnicorandilbeforereperfusionforacutemyocardialinfarctioninpatientswithstresshyperglycemia.DiabetesCare.2006;29(2):202-6.congestiveheartfailureandpredictiveof30-dayuntowardclinicaloutcomesinpatientswithacutemyocardialinfarctionundergoingprimarypercutaneouscoronaryintervention.CircJ.2006;70(2):163-8.KatayamaT,NakashimaH,YonekuraT,HondaY,SuzukiS.Clinicalsignificanceofacute-phasebrainnatriureticpeptideinacutemyocardialinfarctiontreatedwithdirectcoronaryangioplasty.JCardiol.2003;42(5):195-200.LiangJQ,ZhouXX,HuangYG,ZhangGX.EffectofprimarypercutaneouscoronaryinterventiononplasmaB-typenatriureticpeptideinpatientswithacutemyocardialinfarction.DiYiJunYiDaXueXueBao.2005KoYG,JungJH,ParkS,ChoiE,JoungB.Inflammatoryandvasoactivefactorsintheaspiratefromtheculpritcoronaryarteryofpatientswithacutemyocardialinfarction.IntJCardiol.2005;22:120-7YipHK,WuCJ,ChangHW,YangCH,YuTH.Prognosticvalueofcirculatinglevelsofendothelin-1inafteracutemyocardialinfarctionundergoingprimarycoronaryangioplasty.Chest.2005;127(5):1491-SmithSW.STsegmentelevationdiffersdependingonthemethodofmeasurement.AcadEmergMed.AkgulO,SimsekD,ErdemI,OkmenE,CamN.EffectoftirofibantherapyonSTsegmentresolutionandclinicaloutcomesinpatientswithSTsegmentelevatedacutemyocardialinfarctionundergoingprimaryangioplasty.Cardiology.SorajjaP,GershBJ,CostantiniC,McLaughlinMG,ZimetbaumP.CombinedprognosticutilityofST-segmentHeartJ.2005;26(7):667-74.BellandiF,LeonciniM,MaioliM,TosoA,GallopinM.Markersofmyocardialreperfusionaspredictorsofleftventricularfunctionrecoveryinacutemyocardialinfarctiontreatedwithprimaryangioplasty.ClinCardiol.BrodieBR,StuckeyTD,HansenC,VerSteegDS,MuncyDB.RelationbetweenelectrocardiographicST-segmentresolutionandearlyandlateoutcomesafterprimarypercutaneouscoronaryinterventionforacutemyocardialinfarction.AmJCardiol.2005;95(3):343-8.PoloczekM,KalaP,NeugebauerP,BrychtaT,BocekO.ST-segmentresolutionasasimpletoolfortheassessmentofsuccessfulprimarycoronaryinterventionatamicrovascularlevel.VnitrLek.2004;50(10):740-5.perfusiongradingwithsumSTsegmentresolutioninpatientswithacutemyocardialinfarction.ZhonghuaYiXueZaBalianV,GalliM,RepettoS,LuviniM,GaldangeloF.IntracoronarySTsegmentevolutionduringprimarycoronarystentingpredictsinfarctzonerecovery.CatheterCardiovascInterv.2005;64(1):53-60.BonnemeierH,OrtakJ,WiegandUK,EberhardtF,BodeF.Acceleratedidioventricularrhythminthepost-intervention.AnnNoninvasiveElectrocardiol.2005;10(2):179-87.KinjoK,SatoH,SatoH,OhnishiY,HishidaE.Prognosticsignificanceofatrialfibrillation/atrialflutterinpatientswithacutemyocardialinfarctiontreatedwithpercutaneouscoronaryintervention.AmJCardiol.2003;92(10):1150-4.BauerA,WatanabeMA,BarthelP,SchneiderR,UlmK.QRSdurationandlatemortalityinunselectedpost-infarctionpatientsoftherevascularizationera.EurHeartJ.2006;27(4):427-33.percutaneouscoronaryintervention.ItalHeartJ.2005;6(6):447-52.2:PoloczekM,KalaP,NeugebauerP,BrychtaT,BocekO.ST-segmentresolutionasasimpletoolfortheassessmentofsuccessfulprimarycoronaryinterventionatamicrovascularlevel.VnitrLek.2004;50(10):740-5.3:RomanoM,BuffoliF,LettieriC,AroldiM,TomasiL.Noreflowinpatientsundergoingprimaryangioplastyforacutemyocardialinfarctionathighrisk:incidenceandpredictivefactors.MinervaCardioangiol.2005;53(1):7-14.ventricularfunctionrecoveryinacutemyocardialinfarctiontreatedwithprimaryangioplasty.ClinCardiol.5:OkamuraA,ItoH,IwakuraK,KawanoS,KurotobiT.Effectofreactivehyperemiaaftercoronaryrecanalizationonmyocardialtissuereperfusionbythrombolysisinmyocardialinfarctionflowgradeinacutemyocardialinfarction.AmJ6:BaxM,deWinterRJ,KochKT,SchotborghCE,TijssenJG.Timecourseofmicrovascularresistanceoftheinfarct7:KawanoH,HayashidaT,OhtaniH,KandaM,KoideY.Histopathologicalfindingsoftheno-reflowphenomenonfollowingcoronaryinterventionforacutecoronarysyndrome.IntHeartJ.2005;46(2):327-32.8:BaxM,deWinterRJ,SchotborghCE,KochKT,MeuwissenM.Short-andlong-termrecoveryofleftventricularfunctionpredictedatthetimeofprimarypercutaneouscoronaryinterventioninanteriormyocardialinfarction.JAmCollCardiol.2004;43(4):534-41.9:SatoH,IidaH,TanakaA,TanakaH,ShimodouzonoS.Thedecreaseofplaquevolumeduringcoronaryinterventionhasanegativeimpactoncoronaryflowinacutemyocardialinfarction:amajorrolepercutaneouscoronaryintervention-inducedembolization.JAmCollCardiol.2004;44(2):300-10:KotaniJ,MintzGS,PregowskiJ,KalinczukL,PichardAD.Volumetricintravascularultrasoundevidencethatdistalembolizationduringacuteinfarctinterventioncontributestoinadequatemyocardialperfusiongrade.AmJCardiol.SerraV,PerezdeIslaL,ZamoranoJ,AlmeriaC,RodrigoJL.Usefulnessofparametricimaging-basedquantitativemyocardialcontrastechocardiographyinpredictingthefunctionalrecoveryofakineticsegmentsfollowingprimaryangioplastyinacutemyocardialinfarctionpatients.RevEspCardiol.2005;58(6):649-56.GuiducciV,FioroniS,GiacomettiP,ManariA,GaddiO.Earlyevaluationofcoronarymicrocirculationbytransluminalcoronaryangioplasty..MinervaCardioangiol.2005;53(3):157-64.SongJM,LeeJH,KimYH,KangDH,SongJK.Intravenousversusintracoronarymyocardialcontrast2005;22(10):818-25.15:IwakuraK,ItoH,KawanoS,OkamuraA,KurotobiT.Chronicpre-treatmentofstatinsisassociatedwiththereductionoftheno-reflowphenomenoninthepatientswithreperfusedacutemyocardialinfarction.EurHeartJ.16:SongJM,LeeJH,KimYH,KangDH,SongJK.Intravenousversusintracoronarymyocardialcontrast2005;22(10):818-25.patternsinacutepatients.JCardiovascMed.2006May;7(5):322-7DwivediG,JanardhananR,HayatS,etal.Detectionofresidualinfarct-relatedcoronaryarterystenosisandemissioncomputedtomography.JAmSocEchocardiogr.2006May;19(5):546-51.KaltoftA,BottcherM,SandNP,etal.Sestamibisinglephotonemissioncomputedtomographyimmediatelyafterprimarypercutaneouscoronaryinterventionidentifiespatientsatriskforlargeinfarcts.AmHeartJ.2006NakanoM,WagatsumaK,SatoH,etal.Relationshipbetweenlesionvesselareaandmyocardialsalvageassessedbymyocardialsinglephotonemissioncomputedtomographyinacutemyocardialinfarctionwithstentingafterthrombectomy.JCardiol.2006Mar;47(3):123-31.myocardialinfarction:comparisonoftechnetium-99m-tetrofosminmyocardialsinglephotonemissioncomputedtomographyandcoronaryangiography.JCardiol.2006Mar;47(3):115-21SciagraR,ParodiG,MiglioriniA,etal.ST-segmentanalysistopredictinfarctsizeandfunctionaloutcomeinacutemyocardialinfarctiontreatedwithprimarycoronaryinterventionandadjunctiveabciximabtherapy.AmJCardiol.2006Jan1;97(1):48-54ECG-gatedmyocardialperfusionSPECTofischemicheartdisease:J-ACCESSstudydesign.AnnNuclMed.2006ShirasakiH,NakanoA,UzuiH,etal.Comparativeassessmentof(18)F-fluorodeoxyglucosePETand(99m)Tc-JNuclMedMolImaging.2006Apr4;[Epubaheadofprint]questions.RevMedUnivNavarra.2005Jul-Sep;49(3):31-40.SchindlerTH,NitzscheEU,SchelbertHR,etal.Positronemissiontomography-measuredabnormalresponsesofmyocardialbloodflowtosympatheticstimulationareassociatedwiththeriskofdevelopingcardiovascularevents.JAmCollCardiol.2005May3;45(9):1505-12.IbrahimT,NekollaSG,HornkeM,etal.Quantitativemeasurementofinfarctsizebycontrast-enhancedmagneticresonanceimagingearlyafteracutemyocardialinfarction:comparisonwithsingle-photonemissiontomographyusingTc99m-sestamibi.JAmCollCardiol.2005Feb15;45(4):544-52.SekiH,ToyamaT,HiguchiK,etal.PredictionoffunctionalimprovementofischemicmyocardiumwithBMIPPSPECTand99mTc-tetrofosminSPECTimaging:astudyofpatientswithlargeacutemyocardialinfarctionandreceivingrevascularizationtherapy.CircJ.2005Mar;69(3):311-9.myocardialtissuereperfusionbythrombolysisinmyocardialinfarctionflowgradeinacutemyocardialinfarction.AmJCardiol.2006;97(5):617-23.14:DeLucaL,SardellaG,ProiettiP,BattaglieseA,BenedettiG,Effectsoflevosimendanonleftventriculardiastolicfunctionafterprimaryangioplastyforacuteanteriormyocardialinfarction:aDopplerechocardiographicstudy.JAmSocEchocardiogr.2006;19(2):172-7.15:NaqviTZ,PadmanabhanS,RafiiF,HyuhnHK,MirochaJ.Comparisonofusefulnessofleftventriculardiastolicversussystolicfunctionasapredictorofoutcomefollowingprimarypercutaneouscoronaryangioplastyforacutemyocardialinfarction.AmJCardiol.2006;97(2):160-6.16:YilmazR,CelikS,BaykanM,KasapH,KaplanS.AssessmentofmitralannularvelocitiesbyDopplertissueimaginginpredictingleftventricularthrombusformationafterfirstanterioracutemyocardialinfarction.JAmSocEchocardiogr.2005;18(6):632-7.17
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 小米3小米電視發(fā)布會 課件
- 醫(yī)療糾紛的心得體會模版
- 《大禹治水》教學(xué)設(shè)計
- 大學(xué)生職業(yè)規(guī)劃大賽《地理科學(xué)專業(yè)》生涯發(fā)展展示
- 臨床醫(yī)學(xué)檢驗技術(shù)核心要點
- 精細(xì)化管理護理體系構(gòu)建與實踐
- 民辦學(xué)校校長發(fā)言稿模版
- 玉林消防考試題及答案
- 小區(qū)物業(yè)管理調(diào)研報告
- 智慧教育云解決方案
- 《大眾敏捷制造》課件
- 采礦機器人技術(shù)發(fā)展-全面剖析
- 地質(zhì)勘查合同補充協(xié)議
- 某橋梁工程專項施工方案
- 信息技術(shù)服務(wù)質(zhì)量承諾及保障措施
- GB 19646-2025食品安全國家標(biāo)準(zhǔn)稀奶油、奶油和無水奶油
- 電力交易員試題及答案
- 網(wǎng)約車租賃合同協(xié)議書
- 物業(yè)話術(shù)培訓(xùn)
- 2025年檸條項目可行性研究報告
- 女生日常行為規(guī)范
評論
0/150
提交評論